Altered dynamics of transforming growth factor β(TGF-β) receptors in scleroderma fibroblasts.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 21081531.
- Also identified by DOI 10.1136/ard.2009.127811.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To investigate the difference in the dynamics of transforming growth factor β (TGF-β) receptors between normal and scleroderma fibroblasts. The cell surface expression levels of TGF-β receptors were determined by biotinylation and immunoprecipitation assay. The dynamics of TGF-β receptors on the cell surface was determined by the reversible biotinylation assay. The subcellular localisation of TGF-β receptors was determined by immunoprecipitation using antibodies against clathrin and caveolin. Although the total expression levels of TGF-β receptors were elevated in scleroderma fibroblasts compared with normal fibroblasts, there was no significant difference in the cell surface expression levels of TGF-β receptors between these two groups. However, the internalisation rate of TGF-β receptors was higher in scleroderma fibroblasts compared with normal fibroblasts. Furthermore, caveolin constitutively made a complex with TGF-β receptors, while the interaction of clathrin with TGF-β receptors was marginal in scleroderma fibroblasts. The dynamics of TGF-β receptors on the cell surface is accelerated in scleroderma fibroblasts. Considering that the activation state of TGF-β signalling is regulated by a balance between the clathrin-dependent internalisation and the lipid raft-caveolar internalisation, the accumulation of TGF-β receptors in caveolin-positive vesicles may result in the deceleration of caveolin-dependent internalisation and subsequently lead to the relative acceleration of clathrin-dependent internalisation.
Medical subject headings
- Fibroblasts
- Receptors, Transforming Growth Factor beta
- Scleroderma, Systemic